v3.25.1
Note 7 - Accounts Payable and Accrued Liabilities - Accounts Payable and Accrued Liabilities (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current accounts payable $ 530,751 $ 524,355
Accrued liabilities 250,260 322,548
Deferred accounts payable 1,090,041 999,883
Deferred compensation to directors [1] 1,806,433 1,723,048
Total accounts payable 1,620,792 1,524,238
Total accrued liabilities $ 2,056,693 $ 2,045,596
[1] The director fees and interest accrued under the deferred Compensation Plan where most directors elected to defer 100% of their fees for 2025, 2024, 2023, 2022, 2021 and 2020 excluding Jan Loeb who was nominated to the Board on July 28, 2023, and elected to a three-year term at the annual shareholder meeting on October 12, 2023. This amount also includes the deferred compensation of a former Board advisor per an agreement to defer payments due under an advisor agreement and two previous Board members.